TMC1 and hearing loss disorder: Given the functional correlation between TMC proteins and CIBs in inner ear hair cells, targeted Cib2 gene therapy warrants systematic investigation, with Tmc1’s therapeutic success supporting its potential for treating CIB2-related hearing loss.